Yamada, Yunami
Fujii, Hironori http://orcid.org/0000-0003-0944-7290
Ohata, Koichi
Kato-Hayashi, Hiroko
Watanabe, Daichi
Ishihara, Takuma
Uemura, Shinya
Iwashita, Takuji
Imai, Hisashi
Matsuhashi, Nobuhisa
Takahashi, Takao
Sugiyama, Tadashi
Shimizu, Masahito
Yoshida, Kazuhiro
Suzuki, Akio
Article History
Received: 23 April 2019
Accepted: 28 May 2019
First Online: 3 June 2019
Compliance with ethical standards
:
: K Yoshida received grants, personal fees, and nonfinancial support from Chugai Pharmaceutical Co., Ltd. during the conduct of this study; grants and personal fees from Taiho Pharmaceutical Co., Ltd., Pfizer Inc., and Yakult Honsha Co., Ltd.; and grants from Bristol-Myers Squibb and Kyowa Hakko Kirin Co., Ltd. outside the submitted work. He also received honoraria from Taiho Pharmaceutical Co., Ltd., Pfizer Inc., Chugai Pharmaceutical Co., Ltd., Kyowa Hakko Kirin Co., Ltd., and Yakult Honsha Co., Ltd., and had a consultant or advisory relationship with Taiho Pharmaceutical Co., Ltd. and La Roche, Ltd. T. Takahashi has received honoraria for lectures from Takeda Pharmaceutical Co., Ltd. The other authors have no conflicts of interest to disclose.